| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,173 |
11,616 |
$459K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
7,826 |
7,340 |
$275K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
14,676 |
6,901 |
$169K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,875 |
7,384 |
$91K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,569 |
1,544 |
$87K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,435 |
1,338 |
$68K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
816 |
799 |
$63K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
714 |
697 |
$52K |
| 99050 |
|
3,317 |
3,155 |
$43K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,297 |
1,675 |
$43K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
461 |
445 |
$35K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,270 |
4,019 |
$23K |
| 87807 |
|
1,809 |
1,684 |
$16K |
| 99429 |
|
496 |
485 |
$15K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
160 |
153 |
$11K |
| 99000 |
|
1,169 |
1,115 |
$10K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,255 |
800 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
230 |
223 |
$5K |
| 99384 |
|
33 |
32 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
215 |
197 |
$2K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
242 |
230 |
$2K |
| 99383 |
|
17 |
17 |
$1K |
| 96161 |
|
620 |
602 |
$1K |
| 81003 |
|
493 |
474 |
$786.03 |
| 87634 |
|
18 |
18 |
$424.59 |
| 86308 |
|
32 |
31 |
$116.17 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
215 |
197 |
$22.05 |
| 90686 |
|
149 |
147 |
$17.99 |
| 94760 |
|
34 |
31 |
$16.51 |
| 96160 |
|
519 |
508 |
$2.08 |
| 90671 |
|
102 |
100 |
$0.08 |
| 90651 |
|
30 |
30 |
$0.06 |
| 90656 |
|
318 |
317 |
$0.01 |
| 99051 |
|
1,461 |
1,361 |
$0.00 |
| 90734 |
|
28 |
28 |
$0.00 |
| 90715 |
|
13 |
13 |
$0.00 |
| 90710 |
|
12 |
12 |
$0.00 |
| 90633 |
|
18 |
18 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
27 |
26 |
$0.00 |
| 90680 |
|
14 |
13 |
$0.00 |